Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
D000661:Amphetamine; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001923:Brain Chemistry / Q000187:drug effects; D002421:Caudate Nucleus / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004357:Drug Synergism; D006168:Guinea Pigs; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D008954:Models, Biological; D009069:Movement Disorders / Q000139:chemically induced*; D009638:Norepinephrine / Q000378:metabolism; D010276:Parasympatholytics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D010276:Parasympatholytics; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D000661:Amphetamine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine